Accuracy and acceptability of the 6-day enlite continuous subcutaneous glucose sensor

Diabetes Technology and Therapeutics

Volumn 16, Issue 5, 2014, Pages 277-283

  Bailey, Timothy S ^a   Ahmann, Andrew ^b   Brazg, Ronald ^c   Christiansen, Mark ^d   Garg, Satish ^e   Watkins, Elaine ^f   Welsh, John B ^g   Lee, Scott W ^g  

^a AMCR Institute   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Rainier Clinical Research Center   (United States)

^d Diablo Clinical Research   (United States)

^e UNIVERSITY OF COLORADO DENVER   (United States)

^f Profil Institute for Clinical Research   (United States)

^g MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL;

ABDOMEN; ACCURACY; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BUTTOCK; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PRIORITY JOURNAL; ADOLESCENT; ANALYSIS; BLOOD; CONTROLLED STUDY; DEVICES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PATIENT SATISFACTION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84899087565     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0222     Document Type: Article

References (7)

1. Keenan DB, Mastrototaro JJ, Zisser H, Cooper KA, Raghavendhar G, Lee SW, Yusi J, Bailey TS, Brazg RL, Shah RV: Accuracy of the Enlite 6-day glucose sensor with Guardian and Veo calibration algorithms. Diabetes Technol Ther 2012;14:225-231.
2. Zijlstra E, Heise T, Nosek L, Heinemann L, Heckermann S: Continuous glucose monitoring: Quality of hypoglycaemia detection. Diabetes Obes Metab 2013;15:130-135.
3. Calhoun P, Lum J, Beck RW, Kollman C: Performance comparison of the Medtronic Sof-Sensor and Enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther 2013;15:758-761.
4. Luijf YM, Mader JK, Doll W, Pieber T, Farret A, Place J, Renard E, Bruttomesso D, Filippi A, Avogaro A, Arnolds S, Benesch C, Heinemann L, DeVries JH; AP@Home Consortium: Accuracy and reliability of continuous glucose monitoring systems: A head-To-head comparison. Diabetes Technol Ther 2013;15:722-727.
5. Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV: Effectiveness of sensor-Augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 Study. Pediatr Diabetes 2012;13:6-11.
6. Ramchandani N, Arya S, Ten S, Bhandari S: Real-life utilization of real-Time continuous glucose monitoring: The complete picture. J Diabetes Sci Technol 2011;5:860-870.
7. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group: Threshold-based insulinpump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232.